Topamax Linked To Birth Defects Risk
The Food and Drug Administration issued a warning which stated that women who use the migraine and epilepsy drug Topamax during pregnancy are more likely to give birth to a child with a cleft lip or cleft palate. The children of Topamax users may be up to 21-times more likely to suffer from these birth defects.
In addition to the risk of cleft lip or cleft palate, children whose mothers used Topamax during pregnancy may be at an increased risk of other side effects, including spina bifida, persistent pulmonary hypertension of the newborn (PPHN) and other birth defects.
Women whose children were born with oral cleft defects or other birth defects may be eligible to file a Topamax lawsuit and receive compensation for their injuries. Because oral cleft defects occur during the first trimester of pregnancy, women may have continued taking Topamax while they were unaware that they were pregnant, placing their child at potential risk.
If you or a loved one used Topamax during pregnancy and gave birth to a child with cleft lip, cleft palate or other birth defects, contact the lawyers at Hissey Kientz, LLP for a free legal consultation. You can reach us by calling toll-free at 1-866-275-4454, or by filling out the free case evaluation form located on this page.